天承科技(688603.SH):2023年公司電鍍產品銷售量較上一年明顯增加
格隆匯1月31日丨天承科技(688603.SH)近日在接待機構投資者調研時表示,2023年公司電鍍產品的銷售量較上一年明顯增加。目前國內PCB電鍍添加劑的國產化率較低,電鍍是公司重點發展的方向,公司的不溶性陽極直流和脈衝體系的產品,是真正能帶動行業智能化發展的產品。隨着技術的不斷積累和沉澱,更多客户的認可,天承逐步擴大PCB電鍍添加劑產品銷量,加速PCB電鍍添加劑國產化率的提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.